Literature for clioquinol (T01.012 inhibitor)

Summary Literature

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

    2011
  1. Schimmer,A.D.
    Clioquinol - a novel copper-dependent and independent proteasome inhibitor
    Curr Cancer Drug Targets11, 325-331. PubMed  Europe PubMed DOI  I
  2. 2009
  3. Mao,X., Li,X., Sprangers,R., Wang,X., Venugopal,A., Wood,T., Zhang,Y., Kuntz,D.A., Coe,E., Trudel,S., Rose,D., Batey,R.A., Kay,L.E. and Schimmer,A.D.
    Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma
    Leukemia23, 585-590. PubMed  Europe PubMed DOI  I
  4. 2005
  5. Daniel,K.G., Chen,D., Orlu,S., Cui,Q.C., Miller,F.R. and Dou,Q.P.
    Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells
    Breast Cancer Res7, R897-R908. PubMed  Europe PubMed DOI  I